Snap-8
Cosmetic octapeptide designed for topical application to reduce expression lines
- Class
- Cosmetic peptide
- Half-life
- Not applicable
- Route
- Topical
- Cadence
- Daily
- Evidence
- Weak / anecdotal
Overview
Snap-8 is a cosmetic peptide sold in skincare serums and creams — it's not a therapeutic peptide you inject or take systemically. The molecule is an eight-amino-acid sequence designed to mimic part of SNAP-25, a protein involved in neurotransmitter release at neuromuscular junctions. The pitch is that applying it topically to your face will compete with SNAP-25, reduce acetylcholine release, relax facial muscles slightly, and therefore smooth out wrinkles — a topical 'Botox-like' effect without the needle.
The evidence base is thin and heavily manufacturer-funded. Most published efficacy data come from Lipotec (now Lubrizol), the company that developed and sells the ingredient to cosmetic formulators. Those studies report wrinkle-depth reductions of 30-63% after 28 days of twice-daily application at 10% concentration, measured via silicone replicas and optical profilometry. Independent academic research is sparse, and the few existing studies report more modest results — typically 10-20% improvements. The core problem: peptides this size (~1075 Da, hydrophilic) struggle to penetrate intact skin in pharmacologically meaningful amounts without enhanced delivery methods like microneedles.
Snap-8 is not FDA-approved as a drug, is not intended for systemic use, and has no overlap with the therapeutic peptides PeptideAIx typically covers (GLP-1 agonists, growth-hormone secretagogues, tissue-repair peptides, mitochondrial modulators). It's a cosmetic ingredient — sold to skincare brands, not clinics or compounding pharmacies. If you're looking for something to inject or take systemically for metabolic, regenerative, or longevity goals, this isn't it.
Safety considerations
A few of the safety signals worth knowing — the full list, with dosing context and what to monitor, is inside AIx Core.
- Not approved by FDA, EMA, MHRA, or any other regulator as a drug — sold exclusively as a cosmetic ingredient for topical use.
- Generally well tolerated when applied topically — mild irritation, redness, or temporary sensitivity reported in a small percentage of users.
- Long-term safety and systemic effects are not well documented in peer-reviewed clinical trials. Most safety data come from cosmetic study settings or manufacturer reports, not large independent trials.
+ 2 more safety notes inside AIx Core →
Commonly monitored
Markers and signals people track when researching Snap-8.
- Skin appearance — wrinkle depth, smoothness (if using topically for cosmetic purposes)
- Local skin reactions — redness, irritation, sensitivity at application site
- Cosmetic effect timeline — manufacturer studies suggest 4-8 weeks for visible results
Frequently asked questions
What is Snap-8?
Cosmetic octapeptide designed for topical application to reduce expression lines. Snap-8 is a cosmetic peptide sold in skincare serums and creams — it's not a therapeutic peptide you inject or take systemically. The molecule is an eight-amino-acid sequence designed to mimic part of SNAP-25, a protein involved in neurotransmitter release at neuromuscular junctions. The pitch is that applying it topically to your face will compete with SNAP-25, reduce acetylcholine release, relax facial muscles slightly, and therefore smooth out wrinkles — a topical 'Botox-like' effect without the needle.
How is Snap-8 administered?
Topical, typically daily.
What is the half-life of Snap-8?
Not applicable — Topical-only cosmetic ingredient — not absorbed systemically in meaningful amounts.
Is Snap-8 approved for human use?
Snap-8 is investigational — not approved by the FDA, EMA, or MHRA for human use at the time of writing.
What does the evidence show for Snap-8?
Evidence tier: Weak / anecdotal. Manufacturer-funded studies (Lipotec/Lubrizol) report wrinkle-depth reductions of 30-63% after 28 days of twice-daily 10% topical application, measured via silicone replicas and optical profilometry. Independent replication is limited.
What is commonly monitored when researching Snap-8?
Commonly tracked markers + signals: Skin appearance — wrinkle depth, smoothness (if using topically for cosmetic purposes), Local skin reactions — redness, irritation, sensitivity at application site, Cosmetic effect timeline — manufacturer studies suggest 4-8 weeks for visible results.
Related compounds
Open this in AIx Core for the full picture
Mechanism breakdown, receptor pathway diagram, full safety list, monitored items, source citations, and one-tap add-to-protocol. Free with any account.